Balanced news tone
News Sentiment
LLYC sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
18 relevant articles
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-1.6% over one week, +4.9% over four weeks, trend active, and materially above fair value.
Why Guggenheim Just Got More Bullish on Eli Lilly (LLY) Stock
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
79/100 classification
One-week reaction
-1.6%
Price digesting
Trend fit
Trend active
4.9% over four weeks
Fair value
43.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
12
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
CoinCentral
Direct company coverage
Why Guggenheim Just Got More Bullish on Eli Lilly (LLY) Stock
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 18:37
- Source
- CoinCentral
Traders Union
Direct company coverage
Eli Lilly stock consolidates near $1,100 with continued bullish momentum supported by MACD: weekly forecast
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 23 Jun 2026 07:00
- Source
- Traders Union
ad-hoc-news.de
Direct company coverage
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Traders Union
Direct company coverage
+2.53% for Eli Lilly stock as 113% earnings surge supports growth outlook
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 11 Jun 2026 07:00
- Source
- Traders Union
IndexBox
Direct company coverage
Novo Nordisk vs. Eli Lilly: Wegovy Pill Performance and Stock Outlook in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 06 Jun 2026 07:00
- Source
- IndexBox
IndexBox
Direct company coverage
Eli Lilly (LLY) Stock Analysis: Diversification Strategy and Vaccine Deals in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- IndexBox
Traders Union
Direct company coverage
Eli Lilly stock price forecast: $999.66 support in focus as LLY drops 3.05%
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 29 May 2026 07:00
- Source
- Traders Union
ad-hoc-news.de
Direct company coverage
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Barron's
Direct company coverage
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Barron's
The Economic Times
Direct company coverage
LLY stock jumps 9%: Why Eli Lilly stock is soaring today - Mounjaro, Zepbound sales drive massive earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Feb 2026 08:00
- Source
- The Economic Times
Evrim Ağacı
Direct company coverage
Eli Lilly Soars Past $1 Trillion After Earnings Beat
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- Evrim Ağacı
Evrim Ağacı
Direct company coverage
Eli Lilly Stock Slides Amid Rising Industry Headwinds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Evrim Ağacı
AskTraders
Direct company coverage
Eli Lilly Stock Price (LLY) Holding On To $1000 Ahead of Earnings – What Next?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- AskTraders
Capital.com
Direct company coverage
Eli Lilly stock split: what it means for traders
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2025 08:00
- Source
- Capital.com
Business Insider
Direct company coverage
Eli Lilly: 3-Step Strategy to Dominate the $95 Billion Obesity Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2025 07:00
- Source
- Business Insider
Clinical Trials Arena
Direct company coverage
Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2025 07:00
- Source
- Clinical Trials Arena
GuruFocus
Direct company coverage
ELI LILLY AND CO ROE %: 102.49% — 46% Above Median
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 May 2024 02:22
- Source
- GuruFocus
GuruFocus
Direct company coverage
Eli Lilly and Co (LLY) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2019 12:17
- Source
- GuruFocus